These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 19695901

  • 1. Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver.
    Sahara S, Tanihata H, Sato M, Kawai N, Takasaka I, Minamiguchi H, Nakai M, Sonomura T.
    J Vasc Interv Radiol; 2009 Oct; 20(10):1359-64. PubMed ID: 19695901
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S, Shibata J, Fujiyama S, Tanaka M, Noumaru S, Sato K, Tomita K.
    Hepatogastroenterology; 2003 Oct; 50(51):809-13. PubMed ID: 12828090
    [Abstract] [Full Text] [Related]

  • 3. Tissue tolerance to pelvic intraarterial chemoembolization with cisplatin-lipiodol suspension.
    Li J, Zhao YN, Miao ZJ, Zhu L, Wang ZM, Qin HY, Xi JH.
    Gynecol Oncol; 1993 Jul; 50(1):10-4. PubMed ID: 8394274
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N, Hatano E, Maetani Y, Isoda H, Shibata T, Taura K, Oe S, Naito M, Yasuchika K, Fujii H, Ikai I, Uemoto S.
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [Abstract] [Full Text] [Related]

  • 5. [Effects of experimental hepatic artery embolization with lipiodol and gelatin sponge on liver tissue].
    Sato M, Kishi K, Shioyama Y, Tsuda M, Terada M, Tanaka H, Nakatani K, Sonomura T, Maeda M, Daimon M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb 25; 50(2):107-13. PubMed ID: 2163519
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure.
    Iwamoto T, Kawai N, Sato M, Tanihata H, Takasaka I, Minamiguchi H, Sahara S, Nakata K, Shirai S.
    J Vasc Interv Radiol; 2008 Nov 25; 19(11):1646-51. PubMed ID: 18954767
    [Abstract] [Full Text] [Related]

  • 7. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
    Lu CD, Qi YG, Peng SY.
    Chin Med J (Engl); 1994 Mar 25; 107(3):209-15. PubMed ID: 8088182
    [Abstract] [Full Text] [Related]

  • 8. [Tissue tolerance to pelvic intraarterial chemoembolization].
    Li J.
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jan 25; 28(1):41-3, 61. PubMed ID: 8389277
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the role of cisplatin-conjugated-soluble gelatin sponge: feasibility study in a swine model.
    Ikoma A, Kawai N, Sato M, Minamiguchi H, Nakata K, Nakai M, Sanda H, Sonomura T, Kanayama Y, Sakai Y.
    Cardiovasc Intervent Radiol; 2013 Aug 25; 36(4):1097-104. PubMed ID: 23073562
    [Abstract] [Full Text] [Related]

  • 10. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model.
    Sugimori K, Nozawa A, Morimoto M, Shirato K, Kokawa A, Saito T, Numata K, Tanaka K.
    J Vasc Interv Radiol; 2005 Jun 25; 16(6):849-56. PubMed ID: 15947049
    [Abstract] [Full Text] [Related]

  • 11. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver.
    Sato M, Yamada R, Uchida B, Hedgepeth P, Rosch J.
    Cardiovasc Intervent Radiol; 1993 Jun 25; 16(6):348-54. PubMed ID: 8131165
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
    Kawai N, Sato M, Minamiguchi H, Ikoma A, Sanda H, Nakata K, Sato H, Sakaguchi H, Nakai M, Sonomura T.
    J Vasc Interv Radiol; 2013 Sep 25; 24(9):1383-90. PubMed ID: 23727419
    [Abstract] [Full Text] [Related]

  • 13. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y, Kaminou T, Shabana M, Ihaya T, Otsubo K, Ogawa T.
    Hepatogastroenterology; 2008 Sep 25; 55(81):202-6. PubMed ID: 18507107
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation combined with reduction of hepatic blood flow: effect of Lipiodol on coagulation diameter and ablation time in normal pig liver.
    Chung H, Kudo M, Minami Y, Kawasaki T.
    Hepatogastroenterology; 2007 Sep 25; 54(75):701-4. PubMed ID: 17591045
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
    Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J.
    Hepatology; 2002 May 25; 35(5):1164-71. PubMed ID: 11981766
    [Abstract] [Full Text] [Related]

  • 16. [Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma].
    Yodono H, Tarusawa K, Kanehira J, Fukuda E, Ikami I, Sakaki T, Kamata K, Sasaki D, Sasaki M.
    Gan To Kagaku Ryoho; 1986 Dec 25; 13(12):3476-82. PubMed ID: 3024580
    [Abstract] [Full Text] [Related]

  • 17. [Interventional therapy of hepatic artery-portal vein fistula with gelatin sponge and lipiodol].
    Xu HF, Yang RJ, Chen H, Zhu X.
    Zhonghua Yi Xue Za Zhi; 2011 Apr 19; 91(15):1061-3. PubMed ID: 21609644
    [Abstract] [Full Text] [Related]

  • 18. Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer.
    Morimoto K, Sakaguchi H, Tanaka T, Yamamoto K, Anai H, Hayashi T, Satake M, Kichikawa K.
    Cardiovasc Intervent Radiol; 2008 Apr 19; 31(5):981-5. PubMed ID: 18535857
    [Abstract] [Full Text] [Related]

  • 19. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M, Suzuki H, Yamamoto T, Mamada Y, Mizuno H, Tominaga T, Suga M, Suemori S, Kato Y, Sato A, Yamanouchi E, Sakuyama K, Maeyama S, Shinagawa T, Okabe K.
    Semin Oncol; 1997 Apr 19; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [Abstract] [Full Text] [Related]

  • 20. [Effect of the portal vein injection of cisplatin and lipiodol on rat liver].
    Ono Y, Yoshioka H, Kawakami A, Ishida O, Suzuki T.
    Gan To Kagaku Ryoho; 1989 Oct 19; 16(10):3429-34. PubMed ID: 2552932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.